Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
1(8%)
Results Posted
40%(4 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
2
15%
Ph phase_2
1
8%
Ph phase_3
2
15%
Ph phase_1
5
38%
Ph phase_4
3
23%

Phase Distribution

5

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
5(38.5%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
3(23.1%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(10)
Terminated(2)

Detailed Status

Completed10
Terminated1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (38.5%)
Phase 21 (7.7%)
Phase 32 (15.4%)
Phase 43 (23.1%)
N/A2 (15.4%)

Trials by Status

terminated18%
withdrawn18%
completed1077%
recruiting18%

Recent Activity

1 active trials
Showing 5 of 13
withdrawnphase_4

A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs

NCT06708611
completedphase_3

TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure

NCT03296813
completedphase_3

Torsemide Comparison With Furosemide for Management of Patients With Stable Heart Failure

NCT05093621
recruitingphase_4

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

NCT06218199
completedphase_4

Weight-Based Torsemide Dosing in Subjects With Heart Failure

NCT03187509
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT06708611Phase 4

A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs

Withdrawn
NCT03296813Phase 3

TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure

Completed
NCT05093621Phase 3

Torsemide Comparison With Furosemide for Management of Patients With Stable Heart Failure

Completed
NCT06218199Phase 4

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

Recruiting
NCT03187509Phase 4

Weight-Based Torsemide Dosing in Subjects With Heart Failure

Completed
NCT02813551Phase 2

ToRsemide for pOstpartum HYpertension

Completed
NCT01558674Phase 1

A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)

Terminated
NCT00602303Not Applicable

Bioequivalency Study of Torsemide Tablets Under Fasting Conditions

Completed
NCT00602615Not Applicable

Bioequivalency Study of Torsemide Tablets Under Fed Conditions

Completed
NCT01788254Phase 1

Open Label Study for the Functional Characterization of Drug Metabolism and Transport

Completed
NCT01845194Phase 1

Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics

Completed
NCT00653549Phase 1

Bioavailability Study of Torsemide Tablets Under Fasting Conditions

Completed
NCT00654043Phase 1

Bioavailability Study of Torsemide Tablets Under Fed Conditions

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13